Apotex, Cipla resolve claims over Dymista patent
Ashurst 2019-02-18 1:34 pm By Cat Fredenburgh | Melbourne
Please login to bookmark Close

Canadian generic manufacturer Apotex has agreed to drop its lawsuit against India’s Cipla seeking to invalidate its Australian patent for popular nasal spray Dymista.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au